
|Articles|August 23, 2022
Daily Medication Pearl: Seizalam
Author(s)Saro Arakelians, PharmD
Seizalam is a benzodiazepine indicated for the treatment of status epilepticus in adults.
Advertisement
Medication Pearl of the Day: Midazolam injection (Seizalam)
Indication: Seizalam is a benzodiazepine indicated for the treatment of status epilepticus in adults.
Insight:
- Dosing: Injection: 50 mg/10 mL (5 mg/mL) in a multiple-dose vial.
- Dosage forms: The recommended dose is 10 mg, administered by intramuscular injection.
- Adverse events: The most common adverse reactions (incidence >3%) in clinical trials in patients with status epilepticus were upper airway obstruction, agitation, and pyrexia.
- Mechanism of action: The exact mechanism of action for midazolam in the treatment of status epilepticus is not fully understood but is thought to involve potentiation of GABAergic neurotransmission resulting from binding at the benzodiazepine site of the GABAA receptor.
Source: 
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Accelerated Approval of Cancer Drugs: Benefit or Burden?
2
FDA, HHS Move to Accelerate Biosimilar Approvals
3
Pharmacists Lead the Way in Evolving CAR T-Cell and Bispecific Antibody Therapy Management
4
COVID-19 mRNA Vaccines May Boost Immunotherapy Response in Cancer
5


















































































































































































































